Skip to main content

Table 1 Demographics and clinical characteristics of the study subjects

From: Assessment of tear film lipid layer thickness in patients with Meibomian gland dysfunction at different ages

Variables

All group

(n = 209)

Young group

(n = 77)

Middle-aged group

(n = 52)

Older group

(n = 80)

P

Age (y)

51 (33)

29 (8)

51 (7.75)

66 (13)

< 0.001

Sex (male/female)

77/132

28/49

18/34

31/49

0.885

OSDI score

23 (27)

31 (20.5)

29.5 (24.75)

14 (18.75)

< 0.001

LLT (nm)

57 (36.5)

51 (23.5)

59.5 (46.5)

62 (42.5)

0.026

Eyelid margin abnormality

2 (1)

2 (1)

2 (1)

2 (0)

0.001

MGE score

8 (10)

11 (9)

6 (11.25)

7.5 (8)

0.001

Schirmer’s I test (mm)

7 (12.5)

15 (19)

5 (7.75)

6 (6.75)

< 0.001

ITBUT (sec)

3 (2)

2.7 (2)

2.3 (1.23)

3 (2)

0.263

CFS score

1 (2)

1 (1)

1 (1)

1 (2)

0.745

NITBUT (sec)

4.4 (3.06)

4.7 (2.56)

4.2 (2.97)

4.0 (3.68)

0.712

Central TMH (mm)

0.18 (0.1)

0.19 (0.07)

0.19 (0.10)

0.18 (0.08)

0.038

MG dropout (%)

32 (12)

32 (11)

32 (13)

30 (13)

0.972

  1. OSDI Ocular surface disease index; LLT Lipid layer thickness; MGE Meibomian gland evaluator, ITBUT Invasive tear break-up time; CFS Corneal fluorescein staining; NITBUT Non-invasive tear break-up time; TMH Tear meniscus height
  2. All continuous data are expressed as medians (interquartile range, IQR)
  3. Significant data are in bold faceik